RAMASWAMY SRIRAMAN: Open Payments
NPI 1134230857 · GOLDSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,553 in 137 payments from 13 companies in 2025. Trend: 2023 $2,002 · 2024 $2,407 · 2025 $2,553
Food & beverage: $2,553
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $496 |
| Neurocrine BioSciences, Inc. | 23 | $420 |
| Vanda Pharmaceuticals Inc. | 18 | $364 |
| E.R. Squibb & Sons, L.L.C. | 12 | $292 |
| Otsuka America Pharmaceutical, Inc. | 16 | $263 |
| Alkermes, Inc. | 11 | $252 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $151 |
| Axsome Therapeutics, Inc. | 2 | $140 |
| Janssen Pharmaceuticals, Inc | 3 | $60 |
| Lundbeck LLC | 3 | $60 |
Products named: VRAYLAR, INGREZZA, HETLIOZ, COBENFY, REXULTI, CAPLYTA, Auvelity, ARISTADA.
Industry payments across NC — which companies pay providers there.
